Liquidia Technologies is trading at $43.98, up 4.22%, with no clear company-specific announcement explaining the November 4 pre-market move.

  • The company’s Q3 results are scheduled for November 10.
  • Broader markets were positive: the S&P 500 rose 0.73% and the Dow rose 1.50%. This supportive tone may be relevant but does not establish the stock’s cause of movement.
  • The October 13 United Therapeutics settlement is earlier news, not a confirmed new catalyst.